Estimates Revisions SOPHiA GENETICS SA Börse Stuttgart
Stocks
90B
CH1125843347
Advanced Medical Equipment & Technology
|
Delayed
Börse Stuttgart
08:47:16 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 6.700 EUR | -1.47% |
|
-5.63% | +72.68% |
| 08-04 | SOPHiA GENETICS SA, Q2 2026 Earnings Call, Aug 04, 2026 | |
| 08-04 | Sophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
SOPHiA GENETICS SA(SOPH)
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| - | - | ||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- SOPH Stock
- 90B Stock
- Consensus SOPHiA GENETICS SA
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
